Harbin Pharmaceutical Group Co., Ltd.SSE: 600664

(600664)"Harbin Pharmaceutical Group Co., Ltd."Announcement on the Affiliated Enterprise's Receipt of the Approval Notice for the Marketing Application of a Chemical API

· Issued by Harbin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 600664 · · 2 pages · Chinese

Summary by 6ix AI

Harbin Pharmaceutical Group Co., Ltd. announced that its subsidiary has received approval for the marketing application of a chemical active pharmaceutical ingredient.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/600664harbin-pharmaceutical-group-co-ltdannouncement-on-the-affiliated-enterprises-receipt-of-the-approval-notice-for-the-marketing-application-of-a-chemical-api

Release

Announcement on the Affiliated Enterprise's Receipt of the Approval Notice for the Marketing Application of a Chemical API

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

Harbin Pharmaceutical Group Co., Ltd. on 6ix

Story so far

Earlier from Harbin Pharmaceutical

All Harbin Pharmaceutical news releases